Musk Proposes to Proceed With Twitter Deal
Bloomberg Businessweek
00:00
Is Pfizer Going Forward With MNA?
The hope that Pfizer and its competitor Moderna have here is that they can really compress the production timeline for a shot. The company wants to add 25 billion in revenue just via MNA through 2023. Wall Street doesn't feel too bullish about Pfizer right now the stock is down 25% to date this year.
Play episode from 17:32
Transcript
